Structural variation (SV)
Variation that arises via deletion, insertion, or rearrangement of the DNA. Types of structural variation include: Indels: generated from the insertion or deletion of genetic segments, typically ranging from 1 base pair to >100 kilobases. Inversions: when a genetic segment is reversed with respect to the flanking DNA sequence. Translocations: when the genetic segment is rearranged between chromosomal locations.
Copy number variation (CNV)
A type of structural variation that results from the repeated gain or loss of a segment of DNA, leading to an ordinal number of segments (0,1, 2, 3, etc.).
Copy number polymorphism (CNP) CNV that segregates at the same location within or between populations.
Allele frequency
The proportion of chromosomes in a population carrying a particular allele. In the case of a biallelic SNP, alleles may be designated as: Minor: the allele observed in the smallest proportion of the population. Major: the allele observed in the largest proportion of the population. Ancestral: the allele that shares the same state as the last common ancestor of all humans. Derived: the allele that is not the same as the last common ancestors.
Haplotype
The linear combination of alleles at linked loci on chromosomal segments, in which the segments may vary in size from a few loci to the entire chromosome length depending on the number of recombination events that have occurred between the chromosomes.
Linkage disequilibrium (LD)
The covariance of allelic state at a pair of loci across a sample of chromosomes from a population (e.g., "A" allele at locus 1 is seen with "B" allele at locus 2, and "a" allele is seen with "b" allele more often than expected). LD can be caused by a lack of free recombination for loci on the same chromosome (e.g., tight genetic linkage for a pair of loci with multiple alleles) or by population substructure in the sample (e.g., genetic drift at unlinked loci and nonrandom mating lead to correlation in allelic state among loci).
Identical by descent (IBD)
Two chromosomal segments are IBD if they are inherited from the same recent ancestor. Although this is a matter of degree, we often define IBD as sharing above and beyond what would be expected by random mating in the population.Two individuals are deemed to be related if they share homologous genetic segments IBD (i.e., parent-offspring pairs share 50% of their genetic segments IBD).
Identical by state (IBS)
Two alleles at a locus are IBS if they share the same DNA sequence. IBS can indicate IBD, but it can also occur due to random pairing of chromosomal segments in the population (i.e., Hardy-Weinberg).
Quantitative trait
A continuous trait that exhibits variability in a population, e.g., height, body mass index, or plasma cholesterol levels.
Qualitative trait
A trait with two discrete designations is binary or dichotomous (e.g., "case" vs. "control"); a trait with multiple unordered categories is nominal (e.g., "green," "blue," or "brown" eyes); and a trait with natural ordering is ordinal (e.g., "low," "normal," or "high" resting heart rate).
Monogenic trait (Mendelian trait)
A dichotomous phenotype determined by a single locus, e.g., attached earlobes is a monogenic trait.
Polygenic trait
A common or complex phenotype that results from the combined effects of many loci and usually nongenetic factors, such as diet and the environment, e.g., type II diabetes is a polygenic trait.
Oligogenic trait
A phenotype that is the result of the combined effects of a few loci and often nongenetic factors, such as diet and the environment, e.g., age-related macular degeneration is an oligogenic trait
The proportion of the phenotypic variability that can be accounted for by a locus or loci segregating in the population. This can be near 100% for monogenic traits and usually much less than 100% for oligogenic and polygenic traits.
Prevalence
The proportion of individuals in a population exhibiting a trait.
Penetrance
The probability of having a phenotype given the genotype, e.g., for a hypothetical disease in which the A locus contributes to the disease, one might have penetrances of P(Disease | AA) = 1%, P(Disease | Aa) = 1.5%, and P(Disease | aa ) = 2.25%. The "a" allele is the predisposing or risk allele.
Genotype relative risk (GRR)
The ratio of penetrances for different genotypes at a locus. Under a multiplicative model, each allelic copy increases the chances of disease by a constant factor, e.g., for the example above, GRR = P(Disease | aa)/P(Disease | Aa) = 1.5 and P(Disease | Aa)/P(Disease | AA) = 1.5.
Genome-wide association studies (GWAS)
The simultaneous investigation of many genotypes (between 10 5 and 10 7 ) assayed on genome-scale SNP arrays for correlation with complex phenotypes in large quantitative or qualitative (case-control) population-based studies, resulting in a p value of association for each SNP. Larger GWAS are typically performed by combining summary statistics for each SNP test from multiple GWAS in a meta-analysis. Single GWAS are typically performed in two stages: Discovery GWAS stage: to identify associated SNPs. Replication stage: to confirm the association of top-ranking SNPs in independent samples.
Whole-exome association studies (WEAS)
The association of all DNA sequence mutations or variants in genome-wide coding regions (i.e., the exome) in large-scale population-based or family-based studies for either complex/oligogenic or Mendelian traits. In contrast to GWAS, the majority of variants in WEAS are rare and require methods that can detect multiple causal mutations or genetic heterogeneity at the traitassociated loci. Therefore, instead of analyzing individual variants, WEAS methods analyze variants within a region or gene as a group and usually rely on collapsing, resulting in a p value of association per locus.
Genetic model
Determines the risk (r) conferred by each allele to the phenotype. For example, an additive model increases the risk r-and 2r-fold for heterozygotes and homozygotes, respectively, and a multiplicative model r-and r 2 -fold for heterozygote and homozygotes, respectively.
Multiple testing burden
Occurs when a large number of statistical tests of the same null hypothesis (i.e., "no association between genotype and phenotype") are considered simultaneously. To overcome this, one may adjust the significance to account for the number of tests performed (i.e., Bonferonni correction). For example, if one million independent tests were performed, the genome-wide significance threshold would be: nominal significance/number of tests = 0.05/1,000,000 = 5 x 10 -8 .
